ARCHIVES

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.

June 2, 2000

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005